健康儿童和青少年内分泌标志物及生育激素的Siemens Atellica免疫分析系统参考区间
本研究在CALIPER健康队列中为Siemens Healthineers Atellica® IM分析仪的11项免疫分析建立参考区间。共招募600名健康参与者(出生至18岁),分析后评估年龄和性别差异并剔除离群值。结果显示9项需年龄分割、7项需性别分割,游离甲状腺素和促甲状腺激素无显著差异。建立的上下限与其他系统存在差异,强调平台特异性参考区间的必要性。
要点
- 9项免疫分析需年龄分割,7项需性别分割。
- 游离甲状腺素和促甲状腺激素无需年龄或性别分割。
- 不同分析系统的参考区间存在差异,需平台特异性区间。
核心结论
- 观察到的年龄和性别趋势与CALIPER其他平台及国际研究 closely mirrored,但建立的上下限与其他健康队列存在差异,凸显平台特异性参考区间的必要性。
研究设计与样本
- 在CALIPER健康队列中招募600名健康参与者(出生至18岁),采集血清样本,为Siemens Healthineers Atellica® IM分析仪的11项免疫分析建立参考区间。
主要发现
- 11项免疫分析中9项需年龄分割(脱氢表雄酮硫酸盐、雌二醇、铁蛋白、叶酸、促卵泡激素、促黄体激素、孕酮、睾酮、维生素B12),7项需性别分割。
- 游离甲状腺素和促甲状腺激素无显著年龄和/或性别差异。
关键数值与推荐
- 参考区间建立方法:40-<120名参与者用稳健法,≥120名参与者用非参数法。
临床怎么用
- 儿科临床决策应使用平台特异性参考区间,避免直接套用其他分析系统的区间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Rapid development in childhood and adolescence combined with lack of immunoassay standardization necessitates the establishment of age-, sex-, and assay-specific reference intervals for immunochemical markers. This study established reference intervals for 11 immunoassays on the new Siemens Healthineers Atellica® IM Analyzer in the healthy CALIPER cohort. METHODS: A total of 600 healthy participants (birth to 18 years) were recruited from the community, and serum samples were collected with informed consent. After sample analysis, age- and sex-specific differences were assessed, and outliers were removed. Reference intervals were established using the robust method (40-<120 participants) or nonparametric method (≥120 participants). RESULTS: Of the 11 immunoassays studied, nine required age partitioning (i.e., dehydroepiandrosterone-sulfate, estradiol, ferritin, folate, follicle-stimulating hormone, luteinizing hormone, progesterone, testosterone, vitamin B12), and seven required sex partitioning. Free thyroxine and thyroid-stimulating hormone demonstrated no significant age- and/or sex-specific differences. CONCLUSIONS: Overall, the age- and sex-specific trends observed closely mirrored those previously reported by CALIPER on other platforms as well as other internationally recognized studies. However, established lower and upper limits demonstrated some discrepancies between published values from healthy cohorts on alternate analytical systems, highlighting differences between manufacturers and the need for platform-specific reference intervals for informed pediatric clinical decision-making.
引用
- Bohn MK, Horn P, League D, et al. Pediatric reference intervals for endocrine markers and fertility hormones in healthy children and adolescents on the Siemens Healthineers Atellica immunoassay system. Clin Chem Lab Med. 2021. PMID: 33957708. doi:10.1515/cclm-2021-0050
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。